Skip to main content
main-content
Top

10-08-2017 | PARP inhibitors | Article

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

Please follow the link below to view this article in full on a third party website. Note that a subscription or payment may be required.​​​​​​​
http://www.nejm.org/doi/full/10.1056/NEJMoa1706450

Related topics